Revosimeline

CAS No. 1810001-96-7

Revosimeline( Revosimeline )

Catalog No. M12776 CAS No. 1810001-96-7

A novel potent cannabinoid receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Revosimeline
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel potent cannabinoid receptor agonist.
  • Description
    A novel potent cannabinoid receptor agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Revosimeline
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1810001-96-7
  • Formula Weight
    335.448
  • Molecular Formula
    C18H29N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N1[C@@]2([H])C[C@H](N(CC3)CCC3(CN4)CC4=O)C[C@]1([H])CC2)OCC
  • Chemical Name
    ethyl (1R,3r,5S)-3-(3-oxo-2,8-diazaspiro[4.5]decan-8-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MJ 15

    MJ 15 is a CB1 receptor antagonist with specificity for the study of obesity-induced diseases.

  • JTE907

    A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively.

  • CB2R/FAAH?modulator-...

    CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting CB2R and FAAH, acting as a CB2R agonist (Ki = 10.8 nM) and FAAH inhibitor (IC50 = 6.2 μM), with a Ki value of 152.9 nM for CB1R.